Search

everythinglearnresearchcommunity

for

Search:↓

Topical eflornithine helps maintain hair reduction after IPL therapy in women with facial hirsutism.

Enhancing Tregs can protect against alopecia areata.

HB-EGF boosts the hair growth ability of stem cells, making it a potential hair loss treatment.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Mycophenolate helps reverse hair loss effects caused by IFN-γ by activating a key hair growth pathway.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

Human foreskin fibroblast–conditioned medium improved hair growth in androgenetic alopecia patients.

Harlequin mutant mice have hair loss due to low AIF protein levels and retroviral element activity.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Blocking the HEDGEHOG-GLI1 pathway can reduce keloid growth and may be a potential treatment.

New compounds were found to help increase hair growth and decrease hair loss.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Verteporfin reduces growth and stem cell traits in rat hair follicle cells by blocking the Hippo pathway.

4-O-Methylhonokiol helps protect skin cells from growth-stopping effects of a protein by regulating growth-related pathways.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Cyproterone acetate effectively treats hirsutism and related conditions.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Finasteride reduces hair growth and is safe for women with excessive hair.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

HASHA is a safe and effective option for chin augmentation.

Using a special laser and skin medication together successfully cleared a skin condition in a pregnant woman.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

DFMO may help control hair growth and treat cancer.

Blocking 11β-HSD1 reduces stress hormone damage in hair growth cells.